RADNOR, Pa. (AP) _ Marinus Pharmaceuticals Inc. (MRNS) on Thursday reported a loss of $9.5 million in its second quarter.
On a per-share basis, the Radnor, Pennsylvania-based company said it had a loss of 24 cents.
Marinus Pharmaceuticals shares have declined 14 percent since the beginning of the year. The stock has nearly quadrupled in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on MRNS at https://www.zacks.com/ap/MRNS